VBFG
AMRX icon

Vishria Bird Financial Group’s Amneal Pharmaceuticals AMRX Stock Holding History

Vishria Bird Financial Group’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$421K Buy
42,064
+272
+0.7% +$2.44K 0.08% 74
2025
Q2 		$338K Hold
41,792
– – 0.11% 75
2025
Q1 		$350K Buy
+41,792
New +$349K 0.12% 67

Other funds holding AMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Vishria Bird Financial Group's AMRX Position: Q3 2025 in Review

Vishria Bird Financial Group increased its Amneal Pharmaceuticals (AMRX) stake by 0.65% in Q3 2025, buying an estimated $2.44K and bringing the position to 42,064 shares worth $421K. The position accounts for 0.08% of the portfolio, ranked #74.

Vishria Bird Financial Group first reported a position in AMRX in Q1 2025 and has held it in 3 quarters since. 248 funds tracked by Wall St. Rank hold AMRX as of Q3 2025.

  • Vishria Bird Financial Group held 42,064 shares of Amneal Pharmaceuticals worth $421K as of Q3 2025.
  • Vishria Bird Financial Group bought 272 Amneal Pharmaceuticals shares in Q3 2025, an estimated $2.44K.
  • Amneal Pharmaceuticals made up 0.08% of Vishria Bird Financial Group's portfolio in Q3 2025, its #74 holding.
  • Vishria Bird Financial Group first reported a position in Amneal Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
  • 248 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2025.

Based on Vishria Bird Financial Group's 13F filing for Q3 2025, filed 21 Oct 2025.